Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.200
+0.160 (7.84%)
Jan 22, 2026, 9:37 AM EST - Market open
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $192.09 million as of January 22, 2026. Its market cap has increased by 103.52% in one year.
Market Cap
192.09M
Enterprise Value
90.33M
1-Year Change
103.52%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $192.09M, a decrease of -81.72%. That is a compound annual growth rate of -30.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 178.12M | 105.07% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 183.47M |
| ProQR Therapeutics | 176.98M |
| Eledon Pharmaceuticals | 175.37M |
| Innate Pharma | 166.67M |
| Rani Therapeutics Holdings | 165.27M |
| Vaxart | 165.17M |
| Protalix BioTherapeutics | 164.86M |
| NeOnc Technologies Holdings | 162.81M |